Financials data is unavailable for this security.
View more
Year on year CV Sciences Inc had relatively flat revenues (16.21m to 16.00m), though the company grew net income from a loss of 8.21m to a gain of 3.10m. A reduction in the cost of goods sold as a percentage of sales from 65.75% to 55.73% was a component in the net income growth despite flat revenues.
| Gross margin | 46.06% |
|---|---|
| Net profit margin | -15.95% |
| Operating margin | -15.96% |
| Return on assets | -26.94% |
|---|---|
| Return on equity | -78.98% |
| Return on investment | -73.44% |
More ▼
Cash flow in USDView more
In 2023, CV Sciences Inc increased its cash reserves by 115.55%, or 706.00k. The company earned 2.25m from its operations for a Cash Flow Margin of 14.08%. In addition the company used 156.00k on investing activities and also paid 1.39m in financing cash flows.
| Cash flow per share | -0.0141 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.0139 |
|---|---|
| Tangible book value per share | 0.0093 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.12 |
|---|---|
| Quick ratio | 0.2530 |
| Total debt/total equity | 0.0116 |
|---|---|
| Total debt/total capital | 0.0114 |
More ▼
